

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.85777299 |
| 2 | microglial cell activation (GO:0001774) | 4.90481561 |
| 3 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.28492477 |
| 4 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.04175593 |
| 5 | macrophage activation (GO:0042116) | 3.86678341 |
| 6 | response to muramyl dipeptide (GO:0032495) | 3.82679936 |
| 7 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.82121900 |
| 8 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.81436248 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68482494 |
| 10 | protein localization to endosome (GO:0036010) | 3.67109083 |
| 11 | cellular extravasation (GO:0045123) | 3.64786648 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.56320686 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.56320686 |
| 14 | positive regulation of antigen processing and presentation (GO:0002579) | 3.53489570 |
| 15 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.50114465 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.45453769 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.42474626 |
| 18 | response to laminar fluid shear stress (GO:0034616) | 3.37088782 |
| 19 | adenosine receptor signaling pathway (GO:0001973) | 3.28594855 |
| 20 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.28005593 |
| 21 | negative regulation of granulocyte differentiation (GO:0030853) | 3.26722238 |
| 22 | negative regulation of bone resorption (GO:0045779) | 3.23138545 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 3.17671765 |
| 24 | barbed-end actin filament capping (GO:0051016) | 3.15356143 |
| 25 | purinergic receptor signaling pathway (GO:0035587) | 3.14379887 |
| 26 | hepatocyte apoptotic process (GO:0097284) | 3.13540873 |
| 27 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.12551527 |
| 28 | regulation of antigen processing and presentation (GO:0002577) | 3.07803195 |
| 29 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05729946 |
| 30 | activation of MAPKKK activity (GO:0000185) | 3.02547391 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.01376575 |
| 32 | COPI coating of Golgi vesicle (GO:0048205) | 2.93381543 |
| 33 | Golgi transport vesicle coating (GO:0048200) | 2.93381543 |
| 34 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.92476924 |
| 35 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.89925307 |
| 36 | response to fluid shear stress (GO:0034405) | 2.89381952 |
| 37 | response to peptidoglycan (GO:0032494) | 2.87786125 |
| 38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84423692 |
| 39 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.83971112 |
| 40 | keratan sulfate catabolic process (GO:0042340) | 2.81363243 |
| 41 | cellular response to fluid shear stress (GO:0071498) | 2.81219809 |
| 42 | type I interferon signaling pathway (GO:0060337) | 2.80689128 |
| 43 | cellular response to type I interferon (GO:0071357) | 2.80689128 |
| 44 | response to type I interferon (GO:0034340) | 2.79535960 |
| 45 | negative regulation of cell killing (GO:0031342) | 2.76833409 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.76833409 |
| 47 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.75932116 |
| 48 | phagocytosis, engulfment (GO:0006911) | 2.75196904 |
| 49 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.72289516 |
| 50 | response to progesterone (GO:0032570) | 2.71627627 |
| 51 | skin morphogenesis (GO:0043589) | 2.70971588 |
| 52 | positive regulation of nuclease activity (GO:0032075) | 2.69417843 |
| 53 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.68770164 |
| 54 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.68597779 |
| 55 | glycosphingolipid catabolic process (GO:0046479) | 2.67049936 |
| 56 | negative regulation of norepinephrine secretion (GO:0010700) | 2.66958975 |
| 57 | T cell migration (GO:0072678) | 2.66077972 |
| 58 | negative regulation of mast cell activation (GO:0033004) | 2.65852603 |
| 59 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.65769645 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.65694893 |
| 61 | cellular response to antibiotic (GO:0071236) | 2.64423975 |
| 62 | detection of other organism (GO:0098543) | 2.63857415 |
| 63 | positive regulation of interferon-alpha production (GO:0032727) | 2.63840021 |
| 64 | tolerance induction (GO:0002507) | 2.62555761 |
| 65 | growth hormone receptor signaling pathway (GO:0060396) | 2.61166650 |
| 66 | negative regulation of bone remodeling (GO:0046851) | 2.60874949 |
| 67 | myeloid leukocyte activation (GO:0002274) | 2.59637506 |
| 68 | vesicle coating (GO:0006901) | 2.58562019 |
| 69 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.58232841 |
| 70 | definitive hemopoiesis (GO:0060216) | 2.57804595 |
| 71 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.56701305 |
| 72 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.55895620 |
| 73 | macroautophagy (GO:0016236) | 2.55031602 |
| 74 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.54287040 |
| 75 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.53724052 |
| 76 | cellular response to unfolded protein (GO:0034620) | 2.53504207 |
| 77 | negative regulation of tissue remodeling (GO:0034104) | 2.53120007 |
| 78 | regulation of interferon-alpha production (GO:0032647) | 2.52742194 |
| 79 | mast cell activation (GO:0045576) | 2.51234908 |
| 80 | regulation of monocyte chemotaxis (GO:0090025) | 2.50097060 |
| 81 | * nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.49151525 |
| 82 | detection of molecule of bacterial origin (GO:0032490) | 2.48921421 |
| 83 | dendritic cell chemotaxis (GO:0002407) | 2.48736492 |
| 84 | regulation of response to interferon-gamma (GO:0060330) | 2.48415923 |
| 85 | positive regulation by symbiont of host defense response (GO:0052509) | 2.48408680 |
| 86 | modulation by symbiont of host defense response (GO:0052031) | 2.48408680 |
| 87 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.48408680 |
| 88 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.48408680 |
| 89 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.48408680 |
| 90 | modulation by symbiont of host immune response (GO:0052553) | 2.48408680 |
| 91 | glucose 6-phosphate metabolic process (GO:0051156) | 2.47848272 |
| 92 | regulation of nuclease activity (GO:0032069) | 2.47344458 |
| 93 | stress fiber assembly (GO:0043149) | 2.47115719 |
| 94 | ER-nucleus signaling pathway (GO:0006984) | 2.47035736 |
| 95 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.45651612 |
| 96 | cell proliferation involved in kidney development (GO:0072111) | 2.45378492 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 2.44017322 |
| 98 | regulation of podosome assembly (GO:0071801) | 2.43671294 |
| 99 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.43166243 |
| 100 | embryonic process involved in female pregnancy (GO:0060136) | 2.42812063 |
| 101 | regulation of defense response to virus by virus (GO:0050690) | 2.41894998 |
| 102 | membrane raft organization (GO:0031579) | 2.41432142 |
| 103 | regulation of extracellular matrix disassembly (GO:0010715) | 2.40862781 |
| 104 | regulation of cellular extravasation (GO:0002691) | 2.40092616 |
| 105 | peptide catabolic process (GO:0043171) | 2.39763786 |
| 106 | sprouting angiogenesis (GO:0002040) | 2.39590086 |
| 107 | positive regulation of type 2 immune response (GO:0002830) | 2.39101630 |
| 108 | activation of Rac GTPase activity (GO:0032863) | 2.38908035 |
| 109 | detection of bacterium (GO:0016045) | 2.38337117 |
| 110 | phagocytosis, recognition (GO:0006910) | 2.37350214 |
| 111 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.37340139 |
| 112 | dendritic cell migration (GO:0036336) | 2.37290815 |
| 113 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.35933748 |
| 114 | sexual reproduction (GO:0019953) | 2.34943517 |
| 115 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.34906698 |
| 116 | establishment of endothelial barrier (GO:0061028) | 2.34831076 |
| 117 | germinal center formation (GO:0002467) | 2.33343612 |
| 118 | glycolipid catabolic process (GO:0019377) | 2.33314233 |
| 119 | immunoglobulin mediated immune response (GO:0016064) | 2.32999498 |
| 120 | positive regulation of chemokine secretion (GO:0090197) | 2.32585615 |
| 121 | adhesion of symbiont to host (GO:0044406) | 2.32519703 |
| 122 | mannose metabolic process (GO:0006013) | 2.32334524 |
| 123 | histamine secretion (GO:0001821) | 2.32168082 |
| 124 | lipoxygenase pathway (GO:0019372) | 2.31990592 |
| 125 | detection of external biotic stimulus (GO:0098581) | 2.31685107 |
| 126 | positive regulation of p38MAPK cascade (GO:1900745) | 2.30820028 |
| 127 | cellular response to topologically incorrect protein (GO:0035967) | 2.30689658 |
| 128 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.30641985 |
| 129 | regulation of chemokine secretion (GO:0090196) | 2.28574479 |
| 130 | positive regulation of cholesterol efflux (GO:0010875) | 2.28118095 |
| 131 | positive regulation of interferon-beta production (GO:0032728) | 2.27791924 |
| 132 | negative regulation of necroptotic process (GO:0060546) | 2.27706977 |
| 133 | amyloid precursor protein catabolic process (GO:0042987) | 2.26062645 |
| 134 | neutrophil activation involved in immune response (GO:0002283) | 2.25226923 |
| 135 | positive regulation of extracellular matrix organization (GO:1903055) | 2.25218078 |
| 136 | regulation of necroptotic process (GO:0060544) | 2.22835844 |
| 137 | signal complex assembly (GO:0007172) | 2.21692541 |
| 138 | regulation of type 2 immune response (GO:0002828) | 2.20279171 |
| 139 | ER overload response (GO:0006983) | 2.19221015 |
| 140 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.14189561 |
| 141 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.13403306 |
| 142 | regulation of ARF protein signal transduction (GO:0032012) | 2.13050873 |
| 143 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.11800194 |
| 144 | amyloid precursor protein metabolic process (GO:0042982) | 2.11292336 |
| 145 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.09262824 |
| 146 | protein hydroxylation (GO:0018126) | 2.07856103 |
| 147 | response to unfolded protein (GO:0006986) | 2.07034245 |
| 148 | dosage compensation (GO:0007549) | 2.04926811 |
| 149 | response to endoplasmic reticulum stress (GO:0034976) | 2.04825008 |
| 150 | regulation of leukocyte degranulation (GO:0043300) | 2.04039057 |
| 151 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.03475499 |
| 152 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.03475499 |
| 153 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.03475499 |
| 154 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.02108857 |
| 155 | negative regulation of innate immune response (GO:0045824) | 2.01979614 |
| 156 | negative regulation of necrotic cell death (GO:0060547) | 2.01133084 |
| 157 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.01105926 |
| 158 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.01022070 |
| 159 | positive regulation of receptor recycling (GO:0001921) | 2.00724587 |
| 160 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.00101991 |
| 161 | cell adhesion mediated by integrin (GO:0033627) | 1.99334514 |
| 162 | positive regulation of protein homooligomerization (GO:0032464) | 1.99324307 |
| 163 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 1.98296924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.50142522 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.78813732 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.78244301 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.56147358 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.45809995 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.29033247 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.15899635 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.76200481 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.74823444 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72491479 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69661135 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.65460184 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62373161 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.61294308 |
| 15 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.60057539 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59733904 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43415544 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.43021042 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29328580 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18459929 |
| 21 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.18003877 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11149611 |
| 23 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09490539 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.09285859 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.06329028 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.04745209 |
| 27 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.02345420 |
| 28 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.93495345 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92349221 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.89265617 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.81332305 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80088935 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.72782631 |
| 34 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72078588 |
| 35 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71409074 |
| 36 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68054665 |
| 37 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67699353 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.67272341 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65309745 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61399344 |
| 41 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60867896 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59897079 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59694463 |
| 44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56810478 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53317348 |
| 46 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.51217279 |
| 47 | * MYB_26560356_Chip-Seq_TH2_Human | 1.50386683 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50345874 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47208286 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.46361064 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45456718 |
| 52 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.44322374 |
| 53 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.39446232 |
| 54 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.39403778 |
| 55 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38372533 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38241587 |
| 57 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.37254088 |
| 58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36486180 |
| 59 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36415306 |
| 60 | * MAF_26560356_Chip-Seq_TH1_Human | 1.36290660 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34478161 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34098767 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32130674 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31906102 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31487202 |
| 66 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31350712 |
| 67 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.31178716 |
| 68 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30423594 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30012136 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29044556 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28077457 |
| 72 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.27796402 |
| 73 | * MYB_26560356_Chip-Seq_TH1_Human | 1.27162823 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.26623005 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25470126 |
| 76 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25084146 |
| 77 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25061974 |
| 78 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24948238 |
| 79 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23685553 |
| 80 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23602655 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22708427 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21685219 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20964738 |
| 84 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20060099 |
| 85 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20060099 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18928527 |
| 87 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.18446742 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18031453 |
| 89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.16070863 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15857809 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14917038 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.14159213 |
| 93 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13773682 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13484283 |
| 95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12238802 |
| 96 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.11150888 |
| 97 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10370649 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08863800 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08091617 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08083528 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07994357 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07042761 |
| 103 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07006325 |
| 104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07000440 |
| 105 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06696680 |
| 106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06642998 |
| 107 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06497701 |
| 108 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06139354 |
| 109 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06012381 |
| 110 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05599383 |
| 111 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05513890 |
| 112 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04998627 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04356753 |
| 114 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04227930 |
| 115 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.03825395 |
| 116 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03459968 |
| 117 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03147069 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02782403 |
| 119 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02537994 |
| 120 | * MAF_26560356_Chip-Seq_TH2_Human | 1.02101338 |
| 121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01956338 |
| 122 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01874196 |
| 123 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01506199 |
| 124 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00772095 |
| 125 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00347385 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98710088 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98019750 |
| 128 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97624135 |
| 129 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96968823 |
| 130 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96046003 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94220333 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92021941 |
| 133 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91651995 |
| 134 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90696185 |
| 135 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90476472 |
| 136 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89799551 |
| 137 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.88908176 |
| 138 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87020525 |
| 139 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.85867896 |
| 140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85500216 |
| 141 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83354024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.41438289 |
| 2 | MP0008260_abnormal_autophagy | 3.33634201 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.24346369 |
| 4 | MP0003329_amyloid_beta_deposits | 2.82377575 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.66495865 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.56062294 |
| 7 | MP0005671_abnormal_response_to | 2.51509540 |
| 8 | MP0006082_CNS_inflammation | 2.44817596 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.40594864 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.38466973 |
| 11 | MP0003279_aneurysm | 2.31363754 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.25388167 |
| 13 | MP0003436_decreased_susceptibility_to | 2.25313288 |
| 14 | MP0009278_abnormal_bone_marrow | 2.24749069 |
| 15 | MP0009785_altered_susceptibility_to | 2.21100422 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.17975026 |
| 17 | MP0001873_stomach_inflammation | 2.17620999 |
| 18 | MP0002419_abnormal_innate_immunity | 2.15361733 |
| 19 | MP0000604_amyloidosis | 2.02835908 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.99742131 |
| 21 | MP0008438_abnormal_cutaneous_collagen | 1.97947211 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.97188030 |
| 23 | MP0005387_immune_system_phenotype | 1.96416111 |
| 24 | MP0001790_abnormal_immune_system | 1.96416111 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.94997961 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.93503974 |
| 27 | MP0003828_pulmonary_edema | 1.88179329 |
| 28 | MP0004883_abnormal_blood_vessel | 1.86239454 |
| 29 | MP0000685_abnormal_immune_system | 1.83282169 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.82118330 |
| 31 | MP0001800_abnormal_humoral_immune | 1.80414436 |
| 32 | MP0002405_respiratory_system_inflammati | 1.75411492 |
| 33 | MP0002723_abnormal_immune_serum | 1.71648912 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.71530833 |
| 35 | MP0005670_abnormal_white_adipose | 1.71093291 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.66172513 |
| 37 | MP0001819_abnormal_immune_cell | 1.65578719 |
| 38 | MP0003690_abnormal_glial_cell | 1.65322194 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.60425319 |
| 40 | MP0002254_reproductive_system_inflammat | 1.60349216 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.55460929 |
| 42 | MP0005451_abnormal_body_composition | 1.54735263 |
| 43 | MP0005025_abnormal_response_to | 1.52208518 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.51383123 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.50865023 |
| 46 | MP0002933_joint_inflammation | 1.50309019 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.49106622 |
| 48 | MP0005503_abnormal_tendon_morphology | 1.48284035 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.46129981 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.46129981 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.45556252 |
| 52 | MP0000343_altered_response_to | 1.44218433 |
| 53 | MP0003075_altered_response_to | 1.43201466 |
| 54 | MP0003045_fibrosis | 1.41960801 |
| 55 | MP0000249_abnormal_blood_vessel | 1.41722356 |
| 56 | MP0005410_abnormal_fertilization | 1.40100585 |
| 57 | MP0006054_spinal_hemorrhage | 1.39430624 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.38732510 |
| 59 | MP0001542_abnormal_bone_strength | 1.38023557 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.36250694 |
| 61 | MP0004947_skin_inflammation | 1.35767986 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.33159672 |
| 63 | MP0004264_abnormal_extraembryonic_tissu | 1.32227627 |
| 64 | MP0005164_abnormal_response_to | 1.31390159 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.30247848 |
| 66 | MP0000767_abnormal_smooth_muscle | 1.27098505 |
| 67 | MP0005390_skeleton_phenotype | 1.24006944 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.22839764 |
| 69 | * MP0008007_abnormal_cellular_replicative | 1.22180673 |
| 70 | MP0003795_abnormal_bone_structure | 1.21857373 |
| 71 | MP0000920_abnormal_myelination | 1.17001648 |
| 72 | MP0001348_abnormal_lacrimal_gland | 1.16989348 |
| 73 | MP0005023_abnormal_wound_healing | 1.15632934 |
| 74 | MP0009840_abnormal_foam_cell | 1.15610239 |
| 75 | MP0000858_altered_metastatic_potential | 1.14283423 |
| 76 | MP0001851_eye_inflammation | 1.13903281 |
| 77 | MP0001853_heart_inflammation | 1.12858977 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 1.12842059 |
| 79 | MP0002132_abnormal_respiratory_system | 1.10395207 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.10259336 |
| 81 | MP0005165_increased_susceptibility_to | 1.09798592 |
| 82 | MP0003172_abnormal_lysosome_physiology | 1.09704206 |
| 83 | MP0000013_abnormal_adipose_tissue | 1.09305087 |
| 84 | MP0004859_abnormal_synaptic_plasticity | 1.08805041 |
| 85 | MP0000716_abnormal_immune_system | 1.08574859 |
| 86 | MP0002398_abnormal_bone_marrow | 1.08457620 |
| 87 | MP0003091_abnormal_cell_migration | 1.07036870 |
| 88 | MP0003303_peritoneal_inflammation | 1.06518216 |
| 89 | MP0001216_abnormal_epidermal_layer | 1.06511215 |
| 90 | MP0003950_abnormal_plasma_membrane | 1.06386036 |
| 91 | MP0004147_increased_porphyrin_level | 1.05601023 |
| 92 | * MP0003943_abnormal_hepatobiliary_system | 1.04538813 |
| 93 | MP0005166_decreased_susceptibility_to | 1.03769196 |
| 94 | MP0002332_abnormal_exercise_endurance | 1.03505331 |
| 95 | MP0002928_abnormal_bile_duct | 1.02677921 |
| 96 | MP0003448_altered_tumor_morphology | 1.01388996 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 1.01343430 |
| 98 | MP0003634_abnormal_glial_cell | 1.00793860 |
| 99 | MP0004510_myositis | 0.99963051 |
| 100 | MP0008469_abnormal_protein_level | 0.99886686 |
| 101 | MP0005621_abnormal_cell_physiology | 0.99004143 |
| 102 | MP0005076_abnormal_cell_differentiation | 0.98719442 |
| 103 | MP0005310_abnormal_salivary_gland | 0.98462388 |
| 104 | MP0008874_decreased_physiological_sensi | 0.98409764 |
| 105 | MP0002796_impaired_skin_barrier | 0.97585765 |
| 106 | MP0010307_abnormal_tumor_latency | 0.97476732 |
| 107 | MP0001849_ear_inflammation | 0.96154892 |
| 108 | MP0000689_abnormal_spleen_morphology | 0.95158687 |
| 109 | MP0003566_abnormal_cell_adhesion | 0.92473783 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.92085588 |
| 111 | MP0002006_tumorigenesis | 0.91891239 |
| 112 | * MP0002429_abnormal_blood_cell | 0.89962985 |
| 113 | MP0008961_abnormal_basal_metabolism | 0.88598581 |
| 114 | MP0009697_abnormal_copulation | 0.88342541 |
| 115 | MP0005646_abnormal_pituitary_gland | 0.88209994 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.87953082 |
| 117 | MP0005409_darkened_coat_color | 0.87897859 |
| 118 | MP0002722_abnormal_immune_system | 0.87765666 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.87754461 |
| 120 | MP0001243_abnormal_dermal_layer | 0.87218703 |
| 121 | MP0002396_abnormal_hematopoietic_system | 0.86428073 |
| 122 | MP0009764_decreased_sensitivity_to | 0.85241184 |
| 123 | MP0002009_preneoplasia | 0.85219069 |
| 124 | MP0001502_abnormal_circadian_rhythm | 0.83953943 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.82969264 |
| 126 | MP0001915_intracranial_hemorrhage | 0.82693938 |
| 127 | MP0002060_abnormal_skin_morphology | 0.81007227 |
| 128 | MP0005275_abnormal_skin_tensile | 0.79587279 |
| 129 | MP0010352_gastrointestinal_tract_polyps | 0.78527065 |
| 130 | MP0005501_abnormal_skin_physiology | 0.75565976 |
| 131 | MP0001501_abnormal_sleep_pattern | 0.74996281 |
| 132 | MP0003866_abnormal_defecation | 0.71590968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.09919993 |
| 2 | Glomerulonephritis (HP:0000099) | 3.99642417 |
| 3 | Neurofibrillary tangles (HP:0002185) | 3.64569496 |
| 4 | Prostate neoplasm (HP:0100787) | 3.52873911 |
| 5 | Myositis (HP:0100614) | 3.48619061 |
| 6 | Orchitis (HP:0100796) | 3.46625130 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.43936176 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.25560594 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.24477018 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.24187825 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.21819051 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.17176761 |
| 13 | Arterial tortuosity (HP:0005116) | 3.13176388 |
| 14 | Vascular tortuosity (HP:0004948) | 3.10966736 |
| 15 | Loss of speech (HP:0002371) | 3.10927160 |
| 16 | Cervical subluxation (HP:0003308) | 3.06691565 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.04392321 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 3.02576161 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.01702366 |
| 20 | Optic neuritis (HP:0100653) | 3.01702366 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00177505 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00177505 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00177505 |
| 24 | Complement deficiency (HP:0004431) | 2.98902591 |
| 25 | Stomach cancer (HP:0012126) | 2.91878695 |
| 26 | Abnormal gallbladder physiology (HP:0012438) | 2.83562820 |
| 27 | Cholecystitis (HP:0001082) | 2.83562820 |
| 28 | Chronic diarrhea (HP:0002028) | 2.80879409 |
| 29 | Spinal rigidity (HP:0003306) | 2.76289791 |
| 30 | Neuronal loss in central nervous system (HP:0002529) | 2.73350378 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.68638998 |
| 32 | Growth hormone excess (HP:0000845) | 2.67465199 |
| 33 | Upper limb amyotrophy (HP:0009129) | 2.66881696 |
| 34 | Distal upper limb amyotrophy (HP:0007149) | 2.66881696 |
| 35 | Abnormality of complement system (HP:0005339) | 2.66277259 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.64614068 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.63158089 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.63158089 |
| 39 | Colitis (HP:0002583) | 2.63120530 |
| 40 | Nuclear cataract (HP:0100018) | 2.61411428 |
| 41 | Amyloidosis (HP:0011034) | 2.61308102 |
| 42 | Apathy (HP:0000741) | 2.59467494 |
| 43 | Aortic aneurysm (HP:0004942) | 2.57689680 |
| 44 | Cellulitis (HP:0100658) | 2.54677130 |
| 45 | Urethral obstruction (HP:0000796) | 2.54097560 |
| 46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.48726268 |
| 47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.48726268 |
| 48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.48726268 |
| 49 | Diminished motivation (HP:0000745) | 2.47513441 |
| 50 | Hematochezia (HP:0002573) | 2.41374865 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.39776519 |
| 52 | Distal lower limb amyotrophy (HP:0008944) | 2.39508140 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.38469827 |
| 54 | Alveolar cell carcinoma (HP:0006519) | 2.38057865 |
| 55 | Recurrent bacterial skin infections (HP:0005406) | 2.33842834 |
| 56 | Petechiae (HP:0000967) | 2.31683957 |
| 57 | Nephritis (HP:0000123) | 2.31617513 |
| 58 | Abnormal platelet function (HP:0011869) | 2.30528164 |
| 59 | Impaired platelet aggregation (HP:0003540) | 2.30528164 |
| 60 | Ankle clonus (HP:0011448) | 2.29304119 |
| 61 | Tetraparesis (HP:0002273) | 2.28581058 |
| 62 | Arterial thrombosis (HP:0004420) | 2.25853662 |
| 63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.25847467 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.24828231 |
| 65 | Rapidly progressive (HP:0003678) | 2.21357737 |
| 66 | Alopecia of scalp (HP:0002293) | 2.20712691 |
| 67 | Nonimmune hydrops fetalis (HP:0001790) | 2.20518684 |
| 68 | Aortic dissection (HP:0002647) | 2.20325518 |
| 69 | Cerebral aneurysm (HP:0004944) | 2.20242352 |
| 70 | Broad face (HP:0000283) | 2.18821739 |
| 71 | Vertebral compression fractures (HP:0002953) | 2.18812557 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.15078309 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.14947750 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.14023074 |
| 75 | Spondylolisthesis (HP:0003302) | 2.12486282 |
| 76 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.11939355 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.06704177 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06704177 |
| 79 | Joint stiffness (HP:0001387) | 2.05238974 |
| 80 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.03644798 |
| 81 | Follicular hyperkeratosis (HP:0007502) | 2.03338524 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.02304644 |
| 83 | Mitral stenosis (HP:0001718) | 2.02125792 |
| 84 | Gastrointestinal inflammation (HP:0004386) | 2.02018687 |
| 85 | Axonal loss (HP:0003447) | 2.01855266 |
| 86 | Premature rupture of membranes (HP:0001788) | 2.00501527 |
| 87 | Protrusio acetabuli (HP:0003179) | 1.96977913 |
| 88 | Progressive visual loss (HP:0000529) | 1.96299938 |
| 89 | Osteomyelitis (HP:0002754) | 1.96067663 |
| 90 | Thick nail (HP:0001805) | 1.95974862 |
| 91 | Hypokinesia (HP:0002375) | 1.95449572 |
| 92 | Slow saccadic eye movements (HP:0000514) | 1.94587430 |
| 93 | Fatigue (HP:0012378) | 1.94145096 |
| 94 | Mutism (HP:0002300) | 1.92648383 |
| 95 | Subacute progressive viral hepatitis (HP:0006572) | 1.92286239 |
| 96 | Facial diplegia (HP:0001349) | 1.92137245 |
| 97 | Interstitial pulmonary disease (HP:0006530) | 1.91955908 |
| 98 | Distal sensory impairment (HP:0002936) | 1.91584665 |
| 99 | Difficulty climbing stairs (HP:0003551) | 1.89843035 |
| 100 | Recurrent fungal infections (HP:0002841) | 1.89049377 |
| 101 | Glucose intolerance (HP:0000833) | 1.88813758 |
| 102 | Hyperparathyroidism (HP:0000843) | 1.88734323 |
| 103 | Increased IgE level (HP:0003212) | 1.87509760 |
| 104 | Malnutrition (HP:0004395) | 1.87438962 |
| 105 | Upper limb muscle weakness (HP:0003484) | 1.87196366 |
| 106 | Increased CSF protein (HP:0002922) | 1.87094330 |
| 107 | Global brain atrophy (HP:0002283) | 1.85733788 |
| 108 | Metaphyseal cupping (HP:0003021) | 1.84740168 |
| 109 | Decreased motor nerve conduction velocity (HP:0003431) | 1.84479745 |
| 110 | Hypercortisolism (HP:0001578) | 1.84308735 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 1.83164582 |
| 112 | Persistence of primary teeth (HP:0006335) | 1.82819461 |
| 113 | Panhypogammaglobulinemia (HP:0003139) | 1.81923205 |
| 114 | Foot dorsiflexor weakness (HP:0009027) | 1.81649949 |
| 115 | Abnormality of the intrinsic pathway (HP:0010989) | 1.80996275 |
| 116 | Hypoplasia of the odontoid process (HP:0003311) | 1.80657882 |
| 117 | Epistaxis (HP:0000421) | 1.80006475 |
| 118 | Increased connective tissue (HP:0009025) | 1.79741053 |
| 119 | Spinal muscular atrophy (HP:0007269) | 1.78860196 |
| 120 | Micronodular cirrhosis (HP:0001413) | 1.78600975 |
| 121 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.77978887 |
| 122 | Lower limb amyotrophy (HP:0007210) | 1.76936640 |
| 123 | Erythema (HP:0010783) | 1.76815372 |
| 124 | Gingivitis (HP:0000230) | 1.76620425 |
| 125 | Glomerulopathy (HP:0100820) | 1.76279977 |
| 126 | Aortic valve stenosis (HP:0001650) | 1.75661632 |
| 127 | Hammertoe (HP:0001765) | 1.75067935 |
| 128 | IgA deficiency (HP:0002720) | 1.75051170 |
| 129 | J-shaped sella turcica (HP:0002680) | 1.73489666 |
| 130 | Short nail (HP:0001799) | 1.71814213 |
| 131 | Coarse hair (HP:0002208) | 1.71259869 |
| 132 | Agammaglobulinemia (HP:0004432) | 1.70217599 |
| 133 | Ovoid vertebral bodies (HP:0003300) | 1.69895908 |
| 134 | Vasculitis (HP:0002633) | 1.69063704 |
| 135 | Hypoglycemic seizures (HP:0002173) | 1.68285436 |
| 136 | Abnormal glucose tolerance (HP:0001952) | 1.67002250 |
| 137 | Insulin resistance (HP:0000855) | 1.66950750 |
| 138 | Bruising susceptibility (HP:0000978) | 1.66371270 |
| 139 | Myocardial infarction (HP:0001658) | 1.66017052 |
| 140 | Abnormality of the prostate (HP:0008775) | 1.65626233 |
| 141 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.65569700 |
| 142 | Hyperacusis (HP:0010780) | 1.64852467 |
| 143 | Striae distensae (HP:0001065) | 1.64170634 |
| 144 | Peripheral hypomyelination (HP:0007182) | 1.63034423 |
| 145 | Long palpebral fissure (HP:0000637) | 1.62779369 |
| 146 | Recurrent bronchitis (HP:0002837) | 1.62057150 |
| 147 | Biconcave vertebral bodies (HP:0004586) | 1.61544746 |
| 148 | Abnormality of the odontoid process (HP:0003310) | 1.61074180 |
| 149 | Symptomatic seizures (HP:0011145) | 1.60224072 |
| 150 | Recurrent viral infections (HP:0004429) | 1.60015170 |
| 151 | Hand muscle atrophy (HP:0009130) | 1.59865249 |
| 152 | Spastic gait (HP:0002064) | 1.59356313 |
| 153 | Bone pain (HP:0002653) | 1.56683364 |
| 154 | Progressive neurologic deterioration (HP:0002344) | 1.56039756 |
| 155 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.55813073 |
| 156 | Personality changes (HP:0000751) | 1.54900706 |
| 157 | Depression (HP:0000716) | 1.54015726 |
| 158 | Dilatation of the ascending aorta (HP:0005111) | 1.53929456 |
| 159 | Urticaria (HP:0001025) | 1.52879947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.02840482 |
| 2 | TGFBR2 | 3.90095129 |
| 3 | TSSK6 | 3.36149738 |
| 4 | MAPK15 | 3.35493631 |
| 5 | MAP3K14 | 3.33555707 |
| 6 | PDK2 | 3.06562782 |
| 7 | IRAK3 | 2.63509617 |
| 8 | TYK2 | 2.47723071 |
| 9 | PIK3CG | 2.26013538 |
| 10 | TBK1 | 2.13973632 |
| 11 | MAPK7 | 1.93663035 |
| 12 | MST1R | 1.86085461 |
| 13 | ERN1 | 1.84830189 |
| 14 | TXK | 1.82925209 |
| 15 | GRK7 | 1.80597983 |
| 16 | IKBKB | 1.79377911 |
| 17 | MAP4K1 | 1.77619989 |
| 18 | INSRR | 1.76850450 |
| 19 | RIPK1 | 1.75050953 |
| 20 | JAK1 | 1.70465735 |
| 21 | EPHB1 | 1.69223904 |
| 22 | FGFR4 | 1.67972715 |
| 23 | CHUK | 1.64931479 |
| 24 | EPHA3 | 1.62739130 |
| 25 | MAP2K2 | 1.62589696 |
| 26 | NEK9 | 1.62283214 |
| 27 | PIM2 | 1.60031976 |
| 28 | KIT | 1.54589263 |
| 29 | IKBKE | 1.50033676 |
| 30 | TEC | 1.45184975 |
| 31 | STK10 | 1.44642328 |
| 32 | KSR2 | 1.38631327 |
| 33 | NLK | 1.36041983 |
| 34 | MAP3K11 | 1.33820663 |
| 35 | IRAK4 | 1.30695052 |
| 36 | MAP3K1 | 1.27033502 |
| 37 | TESK1 | 1.26187588 |
| 38 | TESK2 | 1.25731296 |
| 39 | RIPK4 | 1.24445908 |
| 40 | MAP3K13 | 1.23519695 |
| 41 | SIK1 | 1.22691020 |
| 42 | KSR1 | 1.21516325 |
| 43 | ZAP70 | 1.18464151 |
| 44 | TAOK2 | 1.16558863 |
| 45 | ARAF | 1.14826681 |
| 46 | CSF1R | 1.13705523 |
| 47 | FES | 1.13574215 |
| 48 | JAK3 | 1.13136437 |
| 49 | PAK6 | 1.12053344 |
| 50 | ICK | 1.08561222 |
| 51 | MAP3K12 | 1.07732213 |
| 52 | TGFBR1 | 1.06949908 |
| 53 | NEK6 | 1.06054324 |
| 54 | CDK8 | 1.05530542 |
| 55 | ITK | 1.05296091 |
| 56 | PTK2 | 1.04039798 |
| 57 | TRIM28 | 1.03731412 |
| 58 | MAP3K3 | 1.03362377 |
| 59 | FLT3 | 1.01973352 |
| 60 | EPHA2 | 1.01372350 |
| 61 | MAP3K2 | 0.98276255 |
| 62 | CLK1 | 0.96482373 |
| 63 | STK38 | 0.94843967 |
| 64 | MOS | 0.88720360 |
| 65 | SIK2 | 0.88557897 |
| 66 | PDPK1 | 0.88505450 |
| 67 | TAOK1 | 0.87959358 |
| 68 | PTK6 | 0.86450831 |
| 69 | KDR | 0.85988280 |
| 70 | SIK3 | 0.85586732 |
| 71 | MST4 | 0.85579916 |
| 72 | LATS2 | 0.85330350 |
| 73 | MARK2 | 0.84915806 |
| 74 | FRK | 0.84719857 |
| 75 | BLK | 0.84159572 |
| 76 | MET | 0.83835805 |
| 77 | FGFR3 | 0.81889532 |
| 78 | TRIB3 | 0.81317260 |
| 79 | NTRK1 | 0.78283418 |
| 80 | PTK2B | 0.77519927 |
| 81 | MAP3K9 | 0.75992246 |
| 82 | LIMK1 | 0.74806387 |
| 83 | RAF1 | 0.74684973 |
| 84 | CAMK1D | 0.74486534 |
| 85 | BCR | 0.73516274 |
| 86 | MAP2K3 | 0.73269467 |
| 87 | LMTK2 | 0.72779520 |
| 88 | PAK4 | 0.69724829 |
| 89 | PRKG2 | 0.68302825 |
| 90 | BMPR1B | 0.66262274 |
| 91 | PDGFRA | 0.66090153 |
| 92 | PRKD3 | 0.65887893 |
| 93 | MAPK11 | 0.65423185 |
| 94 | BTK | 0.64838531 |
| 95 | TRPM7 | 0.63743412 |
| 96 | PRKD2 | 0.63629213 |
| 97 | BMX | 0.63592338 |
| 98 | ZAK | 0.63551787 |
| 99 | MAP3K6 | 0.62122969 |
| 100 | CSK | 0.61491529 |
| 101 | FGR | 0.61241751 |
| 102 | IRAK1 | 0.61238601 |
| 103 | PASK | 0.60486407 |
| 104 | PIM1 | 0.60449512 |
| 105 | MATK | 0.60222210 |
| 106 | SCYL2 | 0.58312763 |
| 107 | EIF2AK2 | 0.57884293 |
| 108 | SGK2 | 0.57879536 |
| 109 | GRK1 | 0.57732478 |
| 110 | MAP3K5 | 0.57480581 |
| 111 | BMPR2 | 0.57362740 |
| 112 | RPS6KA2 | 0.57023759 |
| 113 | SGK3 | 0.56708028 |
| 114 | MAPKAPK2 | 0.56308227 |
| 115 | MAPK12 | 0.56178249 |
| 116 | RET | 0.55695728 |
| 117 | ROCK2 | 0.55370061 |
| 118 | PKN2 | 0.55270045 |
| 119 | LCK | 0.54876567 |
| 120 | VRK1 | 0.54708010 |
| 121 | IRAK2 | 0.53278157 |
| 122 | MTOR | 0.53201132 |
| 123 | JAK2 | 0.52528339 |
| 124 | RPS6KA6 | 0.51606613 |
| 125 | HCK | 0.51384506 |
| 126 | LRRK2 | 0.50399952 |
| 127 | DYRK1B | 0.49312751 |
| 128 | TTN | 0.47866847 |
| 129 | CDK6 | 0.46162699 |
| 130 | IGF1R | 0.45987123 |
| 131 | RPS6KC1 | 0.45764931 |
| 132 | RPS6KL1 | 0.45764931 |
| 133 | PDGFRB | 0.44968427 |
| 134 | MAPKAPK5 | 0.44341952 |
| 135 | ERBB4 | 0.43450421 |
| 136 | TAOK3 | 0.43068354 |
| 137 | NME2 | 0.43051035 |
| 138 | EEF2K | 0.42993865 |
| 139 | MAP3K10 | 0.38973138 |
| 140 | LYN | 0.38462494 |
| 141 | PRKD1 | 0.37695560 |
| 142 | FYN | 0.37197229 |
| 143 | ERBB3 | 0.35481275 |
| 144 | PRPF4B | 0.34855862 |
| 145 | MAPKAPK3 | 0.32594936 |
| 146 | INSR | 0.32156473 |
| 147 | MAPK3 | 0.31756388 |
| 148 | PDK1 | 0.30502459 |
| 149 | PDK4 | 0.29766513 |
| 150 | PDK3 | 0.29766513 |
| 151 | FER | 0.28995694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.88571740 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.40383463 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.33803727 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27236081 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.27193704 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.22327929 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21030380 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.18544448 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08262463 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07514129 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.03998267 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.97685172 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.88625038 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.88540838 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.82743410 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.81032671 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.79530634 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68411584 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.56134668 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54445639 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.43257637 |
| 22 | Apoptosis_Homo sapiens_hsa04210 | 1.40909154 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38166998 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35673886 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31525233 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.30165221 |
| 27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.29491230 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25279749 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.20437104 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19527763 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.17989230 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17061390 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14203376 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14011433 |
| 35 | Prion diseases_Homo sapiens_hsa05020 | 1.13223706 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.11286115 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.11267114 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.10528966 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09310619 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.08886947 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06442918 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.04885933 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.02702190 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02697553 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02303858 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99689677 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99433565 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98956126 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98558789 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98287572 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97091593 |
| 52 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.95885949 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.95637784 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95402853 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94920580 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94853048 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.93678908 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93199201 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92477413 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91898251 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90990618 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86582002 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86418706 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84359144 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 0.84150312 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83924785 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82917166 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82615403 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.82161167 |
| 70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81569150 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80898126 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80855484 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80830611 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79935690 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79724341 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78518411 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76931758 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75106061 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74967048 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.73511120 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73501790 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73165607 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70781443 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.70155829 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.69762944 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68681948 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68639416 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67892121 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67733701 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66303795 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.66197179 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65911255 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64714750 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64377855 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62593235 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62316184 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62140015 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61678948 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.60790381 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60582844 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60425873 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60399267 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59148610 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58791210 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.57795678 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55467217 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55401371 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54136328 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52376872 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51561720 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.51154504 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.50896892 |
| 113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50850467 |
| 114 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49877075 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48825096 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47190636 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47145566 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45012300 |
| 119 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44643812 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43832068 |
| 121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43798836 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43689504 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42620926 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41153032 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37616819 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37464112 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37456162 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33991182 |

